Back to Search
Start Over
Microdialysates of amines and metabolites from core nucleus accumbens of freely moving rats are altered by dizocilpine
- Publication Year :
- 2001
-
Abstract
- In vivo microdialysis combined with high performance liquid chromatography (HPLC) with electrochemical detection, was used to study the effect of MK-801 (0.1 mg/kg i.p.) on extracellular concentrations of dopamine (DA) 3,4-dihydroxyphenylacetic acid (DOPAC), serotonin (5-HT), norepinephrine (NE) and DOPAC/DA ratio in intact, 6-hydroxydopamine (6-OHDA)-lesioned, DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzyl-amine hydrochloride)-lesioned and reserpine-treated rats. The results revealed high basal DA (0.735+/-0.05 fmol/microl), DOPAC (195.93+/-20.18 fmol/microl) and NE (0.585+/-0.01 fmol/microl), low 5-HT (0.334+/-0.032 fmol/microl) and high DOPAC/DA ratio (265.11+/-20.73) in intact cACC. 6-OHDA alone (8 microg/2 microl) depleted DA (-66%), DOPAC (-65%), and NE (-62%). On the other hand, in desipramine (DMI)-pretreated rats, 6-OHDA induced a large depletion of DA (-94%), DOPAC (-97%) and reduced DOPAC/DA ratio (-73%), but increased NE to 142% of intact and 369% of 6-OHDA-lesioned rats. DSP4 (50 mg/kg) decreased NE (-97%), DOPAC (-75%) and DOPAC/DA ratio (-69%). Reserpine (5 mg/kg s.c.) significantly decreased DOPAC (-84%), DOPAC/DA ratio (-81%), 5-HT (-69%) and NE (-86%), but nonsignificantly increased DA. In the intact rats, MK-801 did not change DA, but increased DOPAC and DOPAC/DA ratio. In 6-OHDA-lesioned rats, MK-801 increased DA, whereas in 6-OHDA+DMI rats MK-801 additionally increased DOPAC and DOPAC/DA ratio. DSP4 and reserpine reduced the ability of MK-801 to increase DOPAC and DOPAC/DA ratio. MK-801 did not change NE concentration in dialysates collected from intact rats, but increased that from 6-OHDA+DMI-lesioned rats. In DSP4-lesioned and reserpine-treated rats, MK-801 increased NE but to a level lower than that observed in the intact rats. These results suggest that systemic administration of a low dose of MK-801, which induces profound locomotor stimulation without stereotypy, increases DOPAC and DOPAC/DA ratio in the cACC of intact rats, whereas it additionally increases the depleted DA and NE concentrations especially in 6-OHDA-lesioned rats pretreated with DMI.
- Subjects :
- Male
Benzylamines
Reserpine
Dizocilpine
nucleus accumbens
Metabolite
Microdialysis
Dopamine
3,4 dihydroxyphenylacetic acid
chemistry.chemical_compound
Norepinephrine
Catecholamines
Desipramine
rat
Chromatography, High Pressure Liquid
MK-801
Neurotransmitter Agents
Chemistry
General Neuroscience
drug effect
article
extracellular space
serotonin
dialysate
Neuroprotective Agents
priority journal
3,4-Dihydroxyphenylacetic Acid/metabolism
Animals
Benzylamines/toxicity
Desipramine/pharmacology
Dizocilpine Maleate/*pharmacology
Dopamine/metabolism
Excitatory Amino Acid Antagonists/*pharmacology
Motor Activity/drug effects
Neuroprotective Agents/*pharmacology
Neurotransmitter Agents/*metabolism
Norepinephrine/metabolism
Nucleus Accumbens/*drug effects/metabolism
Oxidopamine/toxicity
Rats
Rats, Wistar
Reserpine/toxicity
catecholamine depletion
medicine.drug
drug antagonism
medicine.medical_specialty
high performance liquid chromatography
noradrenalin
animal experiment
6-OHDA
Motor Activity
2 bromo n (2 chloroethyl) n ethylbenzylamine
drug activity
Internal medicine
oxidopamine
medicine
controlled study
Molecular Biology
nonhuman
noradrenalin brain level
catecholamine brain level
brain injury
Endocrinology
nervous system
Catecholamine
dopamine brain level
3,4-Dihydroxyphenylacetic Acid
Neurology (clinical)
Serotonin
Dizocilpine Maleate
Excitatory Amino Acid Antagonists
Developmental Biology
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....dd3f26ac6c114b7d6cadb588c9607d34